Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
The report found that among pediatric patients infected with COVID-19 and influenza, most hospitalized or deceased patients had underlying conditions and were unvaccinated with fever all over.
Read Full NewsBaseline RV Dysfunction May predict Sotatercept response in PAH
The FDA accepted uniQure's biologics license application for ifezuntirgene inilparvovec and granted it Priority Review, setting a target action date of May 1, 2027.
Pediatric epilepsy care goes beyond seizures, addressing mental health, learning needs, coordinated referrals, equitable access, and smoother transition to adult services.
Sabirnetug failed to meet its primary endpoint in Acumen Pharmaceuticals' phase 2 ALTITUDE-AD trial for early Alzheimer disease, prompting the company to end development.
AL-S Pharma outlined the design of AP101-03, a planned phase 3 trial of AP-101 in sporadic and SOD1-associated ALS, at the 2026 NEALS Annual Meeting.
Alnylam Pharmaceuticals reported initial Phase 1b findings showing brezosiran reduced cerebrospinal fluid mutant huntingtin levels by a mean of 60% to 64% at 3 months, with plans for a pivotal study in 2027.
The executive medical director at AbbVie discussed the FDA approval of tavapadon, the first D1/D5 dopamine agonist for Parkinson disease, including the supporting TEMPO trial data and safety considerations.
1.
Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT
2.
Cancer patients rarely use ancestry testing.
3.
The Effect of Common Steroids on Cancer Treatments.
4.
Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer
5.
Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics
1.
Preventing Cancer-Associated Cachexia Through Early Muscle Proteolysis Signature Monitoring
2.
Exploring the Impact of Adrenal Myelolipoma on the Human Body
3.
Robotic Segmentectomy for Anatomically Complex Tumors: Technical Principles, Evidence, and Clinical Applications
4.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
5.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
2.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
4.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
5.
Recognizing Symptoms That May Require Cancer Evaluation
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge